Bone scan in metabolic bone diseases. Review

被引:0
|
作者
Abdelrazek, Saeid [1 ]
Szumowski, Piotr [1 ]
Rogowski, Franciszek [1 ]
Kociura-Sawicka, Agnieszka [1 ]
Mojsak, Malgorzata [1 ]
Szorc, Malgorzata [2 ]
机构
[1] Med Univ Bialystok, Dept Nucl Med, 13 Waszyngtona Str, PL-15269 Bialystok, Poland
[2] Med Univ Bialystok, Dept Endocrinol Diabetol & Internal Med, Bialystok, Poland
关键词
metabolic bone disease; superscan; focal uptake; Tc-99m diphosphonate;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Metabolic bone disease encompasses a number of disorders that tend to present a generalized involvement of the whole skeleton. The disorders are mostly related to increased bone turnover and increased uptake of radiolabelled diphosphonate. Skeletal uptake of Tc-99m-labelled diphosphonate depends primarily upon osteoblastic activity, and to a lesser extent, skeletal vascularity. A bone scan image therefore presents a functional display of total skeletal metabolism and has valuable role to play in the assessment of patients with metabolic bone disorders. However, the bone scan appearances in metabolic bone disease are often non-specific, and their recognition depends on increased tracer uptake throughout the whole skeleton. It is the presence of local lesions, as in metastatic disease, that makes a bone scan appearance obviously abnormal. In the early stages, there will be difficulty in evaluating the bone scans from many patients with metabolic bone disease. However, in the more severe cases scan appearances can be quite striking and virtually diagnostic.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 50 条
  • [1] Clinical performances of biochemical markers of bone resorption in metabolic bone diseases.
    Dorizzi, RM
    Bertoldo, F
    Zanini, M
    Caputo, M
    Gasperi, E
    Furlan, F
    CLINICAL CHEMISTRY, 1997, 43 : 636 - 636
  • [2] Serum Activin-A levels in metabolic bone diseases.
    Nuti, R
    Martini, G
    Florio, G
    Valenti, R
    Salvadori, S
    Picchi, A
    Petraglia, F
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S254 - S254
  • [3] Utility of Bone scan in the management of metabolic bone diseases: A case-based multimodality pictorial review.
    Abidi, Minhal
    Suthar, Pokhraj
    Virmani, Sumeet
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [4] Pathological and metabolic bone diseases. Clinical importance for fracture treatment
    Oheim, R.
    UNFALLCHIRURG, 2015, 118 (12): : 1007 - 1016
  • [5] DXA is unable to measure differential changes in bone density and microstructure induced by metabolic bone diseases.
    Cory, E.
    Nazarian, A.
    Van der Zwaal, P.
    Hoogwater, F.
    Bohanske, M.
    Snyder, B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S352 - S352
  • [6] BONE AND METABOLIC DISEASES OF BONE
    PLIMPTON, CH
    GUTMAN, AB
    AMERICAN JOURNAL OF MEDICINE, 1953, 15 (01): : 99 - 111
  • [7] BONE SCAN IN DENTAL DISEASES
    TOW, DE
    GARCIA, DA
    JANSONS, D
    SULLIVAN, TM
    NIEDERMAN, R
    JOURNAL OF NUCLEAR MEDICINE, 1978, 19 (07) : 845 - 847
  • [8] Bone Metabolism and Inflammation in Autoimmune Diseases.
    Peichl, P.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2015, 22 (01): : 5 - 9
  • [9] MRI of bone marrow in hematological diseases.
    Roca, M
    Giraldo, P
    Rubio-Félix, D
    Giralt, M
    BLOOD, 1998, 92 (10) : 256B - 256B
  • [10] Evaluation of a new immunoradiometric assay for human osteocalcin in several metabolic bone diseases.
    Body, JJ
    Wantier, H
    Mathieu, F
    Dumon, JC
    CLINICAL CHEMISTRY, 1996, 42 (06) : 600 - 600